CDKN2A and head and neck squamous cell carcinoma: In addition, similar prognostic role of p16 for OS (HR 0.41, 95% CI 0.25-0.69; p<0.001) in 387 non-OPSCC patients was also observed in HNSCC cohort using the US Veterans Affairs database (Bryant et al., 2018).